Related Experiment Video
Updated: Jan 3, 2026
07:54
Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
Published on: September 2, 2014
48.4K
IL-1β Induces SOCS2 Expression in Human Dendritic Cells.
Muamera Sarajlic1, Theresa Neuper1, Kim Tamara Föhrenbach Quiroz1
1Department of Biosciences, University of Salzburg, 5020 Salzburg, Austria.
International Journal of Molecular Sciences
|November 29, 2019
Summary
Suppressor of cytokine signaling 2 (SOCS2) limits interleukin-1 beta (IL-1β)-induced IL-8 secretion in dendritic cells. SOCS2 is upregulated in myeloid leukemia, suggesting a role in these diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial regulators of immunity and inflammation.
- Interleukin-1 beta (IL-1β) is a key cytokine in inflammatory responses and disease pathogenesis.
- Tight regulation of IL-1β signaling is essential for host protection and disease prevention.
Purpose of the Study:
- To investigate the role of Suppressor of Cytokine Signaling 2 (SOCS2) in IL-1β-induced DC activation.
- To determine if SOCS2 expression is modulated by IL-1β stimulation.
- To explore the functional impact of SOCS2 on DC responses to IL-1β.
Main Methods:
- Human monocyte-derived DCs were stimulated with IL-1β.
- SOCS2 mRNA and protein levels were quantified.
- DC activation markers (cytokine secretion, surface markers) were assessed.
- SOCS2 function was analyzed using siRNA-mediated gene silencing.
- SOCS2 expression was examined in a myeloid leukemia patient dataset.
Main Results:
- IL-1β potently induced SOCS2 expression in DCs.
- SOCS2 silencing enhanced IL-1β-induced IL-8 secretion, indicating SOCS2 limits this response.
- SOCS2 levels were significantly elevated in patients with acute and chronic myeloid leukemia.
- IL-1β is implicated in the progression of myeloid leukemia.
Conclusions:
- SOCS2 is identified as a novel IL-1β-inducible gene.
- SOCS2 plays a specific role in limiting IL-1β-induced IL-8 secretion by DCs.
- Elevated SOCS2 in myeloid leukemia suggests a potential role in IL-1β-mediated pathogenesis of these hematological malignancies.
Related Concept Videos
01:24T Cell Types and Functions
2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
01:16TGF - β Signaling Pathway
10.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
02:26NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
01:20The JAK-STAT Signaling Pathway
11.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.6K